Post-replicative lesion processing limits DNA damage-induced mutagenesis
Nucleic Acids Research · 20.03.2025 · 53 (6)
DOI: 10.1093/nar/gkaf198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.03.2025. Verfasst von Katarzyna H Masłowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center of Marseille: Team DNA Damage and Genome Instability. CNRS, Aix Marseille University, Inserm, Institut Paoli-Calmettes, Marsei…. Hauptthemen laut MEDLINE: DNA Damage, Mutagenesis, DNA Replication, DNA Repair. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation pour la Recherche Médicale, Deutsche Forschungsgemeinschaft, Fondation de France.
Abstract (Originalsprache)
DNA lesions are a threat to genome stability. To cope with them during DNA replication, cells have evolved lesion bypass mechanisms: Translesion Synthesis (TLS), which allows the cell to insert a nucleotide directly opposite the lesion, with the risk of introducing a mutation, and error-free damage avoidance (DA), which uses homologous recombination to retrieve the genetic information from the sister chromatid. In this study, we investigate the timing of lesion bypass in yeast and its implications for the accuracy of the process. Our findings reveal that DNA polymerase η can bypass common, UV-induced cyclobutane pyrimidine dimers at the fork, immediately after encountering the blocking lesion. In contrast, TLS at (6–4) photoproducts and bulky G-AAF adducts, mediated by Rev1 and Pol ζ, takes place behind the fork, at post-replicative gaps that are generated downstream of the lesion after repriming. We show that in this latter situation, TLS competes with the DA pathway, thus reducing overall mutagenicity of damage bypass. Additionally, our study demonstrates that Exo1 nuclease influences the balance between TLS and DA by modulating the size of the post-replicative gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Research Center of Marseille: Team DNA Damage and Genome Instability. CNRS, Aix Marseille University, Inserm, Institut Paoli-Calmettes, Marseille 13009, France.
- Institute of Molecular Biology (IMB), 55128 Mainz, Germany.
ORCID-Profile: Katarzyna H Masłowska, Ronald P Wong, Helle D Ulrich, Vincent Pagès
Förderung
- Fondation pour la Recherche Médicale
- Deutsche Forschungsgemeinschaft
- Fondation de France
Zitieren
APA
Masłowska, K. H., Wong, R. P., Ulrich, H. D., & Pagès, V. (2025). Post-replicative lesion processing limits DNA damage-induced mutagenesis. Nucleic Acids Research, 53(6). https://doi.org/10.1093/nar/gkaf198
Vancouver
Masłowska KH, Wong RP, Ulrich HD, Pagès V. Post-replicative lesion processing limits DNA damage-induced mutagenesis. Nucleic Acids Research. 2025;53(6). doi:10.1093/nar/gkaf198
BibTeX
@article{Masowska2025,
author = {Masłowska, Katarzyna H and Wong, Ronald P and Ulrich, Helle D and Pagès, Vincent},
title = {Post-replicative lesion processing limits DNA damage-induced mutagenesis},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {6},
doi = {10.1093/nar/gkaf198}
}
EUVIMED